Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Surgical Artificial Intelligence Innovation Trends and Regulatory Insights: A Systematic Analysis of Food and Drug Administration-Approved Devices.

PMID: 42849513 ·

R, i, s, h, i, k, e, s, h, , G, a, n, d, h, e, w, a, r, ;, , A, h, m, a, d, , G, u, n, i, ;, , D, e, v, a, n, s, h, , T, a, n, d, o, n, ;, , S, o, n, a, m, , P, a, t, e, l, ;, , W, i, l, l, i, a, m, , W, a, l, d, o, c, k, ;, , N, a, f, i, , D, i, l, a, v, e, r, ;, , H, a, o, y, u, , Z, h, a, n, g, ;, , K, r, s, t, o, , P, a, n, d, z, a, ;, , A, r, a, , D, a, r, z, i, ;, , H, u, t, a, n, , A, s, h, r, a, f, i, a, n

JournalAnnals of surgery
Year
PMID42849513

Abstract

To characterise the landscape of surgical artificial intelligence (AI) devices approved by the US Food and Drug Administration (FDA). AI has the potential to improve surgical pathways, offering capability across screening, diagnosis, decision support, and intraoperative care. Despite this, real-world adoption remains limited. Regulatory approval serves as a key step in clinical translation but is influenced by challenges in evidence generation, safety, bias, transparency, and implementation. Con

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑